Show simple item record

dc.contributor.authorTaqi, Hussein
dc.date.accessioned2021-08-03T15:15:12Z
dc.date.available2021-08-03T15:15:12Z
dc.identifier.citationEur Cardiol. 2021 May 13;16:e19. doi: 10.15420/ecr.2020.15.R2. eCollection 2021 Feb.en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12904/14822
dc.description.abstractCardiovascular diseases and psoriasis have been well established as separate entities, however, there is uncertainty with regards to a link between the two diseases. A few environmental, psychological and social factors have been implicated as potential common risk factors that may exacerbate the two diseases, and an array of complex immune and non-immune inflammatory mediators can potentially explain a plausible link. Pharmacotherapy has also played a role in establishing a potential association, especially with the advent of biological agents which directly act on inflammatory factors shared by the two diseases. This review will look at existing evidence and ascertain a potential correlation between the two.
dc.language.isoenen_US
dc.subjectMIen_US
dc.subjectPsoriasisen_US
dc.subjectAtherosclerosisen_US
dc.subjectCardiovascular Risken_US
dc.subjectCytokinesen_US
dc.subjectHyperlipidaemiaen_US
dc.subjectInflammationen_US
dc.subjectIschaemic Heart Diseaseen_US
dc.subjectPathophysiologyen_US
dc.subjectPsoriasis Vulgarisen_US
dc.subjectVascular Diseaseen_US
dc.titleThe Association Between Psoriasis and Cardiovascular Diseases.en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.licenseref.urihttps://www.ecrjournal.com/articles/association-between-psoriasis-and-cardiovascular-diseasesen_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.dateFOA2021-08-03T15:15:13Z
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2021-05
html.description.abstractCardiovascular diseases and psoriasis have been well established as separate entities, however, there is uncertainty with regards to a link between the two diseases. A few environmental, psychological and social factors have been implicated as potential common risk factors that may exacerbate the two diseases, and an array of complex immune and non-immune inflammatory mediators can potentially explain a plausible link. Pharmacotherapy has also played a role in establishing a potential association, especially with the advent of biological agents which directly act on inflammatory factors shared by the two diseases. This review will look at existing evidence and ascertain a potential correlation between the two.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


Files in this item

Thumbnail
Name:
(782) Eur Clin rev.pdf
Size:
584.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record